奮達科技(002681.SZ)預計2019年度計提資產減值準備23.43-29.71億元
格隆匯3月1日丨奮達科技(002681.SZ)公佈,為了更加真實、準確地反映公司截至2019年12月31日的資產狀況和經營成果,公司及下屬子公司對資產進行了全面清查並進行充分的分析和評估,對可能發生資產減值損失的資產計提減值準備。預計公司2019年度計提各類資產減值準備總金額為23.43-29.71億元,範圍包括商譽、存貨、固定資產。
經公司財務部門初步測算,預計公司2019年度計提資產減值準備金額為23.43-29.71億元,公司2019年度合併財務報表所有者權益、淨利潤相應減少23.43-29.71億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.